(“NetScientific”, the “Group” or the “Company”)
London, UK – 04 October 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, today outlines its investor communications timetable for the remainder of the year.
Management will be presenting at a range of virtual retail focussed investor events, to discuss the Company’s recent results and provide an overview on its portfolio and ongoing strategy.
Investor Presentation, 16.00, Thursday 07 October 2021
Dr Ilian Iliev, Chief Executive, and John Clarkson, Executive Chairman, will hold a presentation to cover the results and prospects at 16.00 on Thursday 07 October. The presentation will be hosted through the digital platform Investor Meet Company.
Investors can sign up to Investor Meet Company for free and register to meet NetScientific plc via the following link https://www.investormeetcompany.com/netscientific-plc/register-investor . Investors who have already registered to meet the Company will automatically be invited.
Questions can be submitted pre-event to email@example.com, or in real time during the presentation via the “Ask a Question” function.
The Company will also be presenting at the following virtual events:
- Mello Results Round Up on 14 October
- Proactive One2One event on 4 November
Ilian Iliev, CEO of NetScientific, commented: “As NetScientific continues its growth path utilising the capital light pro-active investment approach, we want to ensure that our shareholders are well informed about the strategy we are following, key developments and potential of our portfolio to deliver added value and realisations for our shareholders. We look forward to the upcoming presentations.”
For more information, please contact:
|NetScientific||Via Walbrook PR|
|Ilian Iliev, CEO|
|WH Ireland (NOMAD, Financial Adviser and Broker)|
|Chris Fielding / Darshan Patel||+44 (0)20 7220 1666|
|Nick Rome/ Paul McManus/
|07748 325 236, 07980 541 893
or 07884 664 686
NetScientific plc (AIM: NSCI) is a holding company, that invests in, develops, commercialises and realises shareholder value in life sciences/healthcare, sustainability and technology companies, which offer significant growth potential predominately in the UK and USA, as well as globally.
With the acquisition of EMV Capital in August 2020, the Group doubled its portfolio from 8 to 17 companies, either through direct subsidiary, balance sheet investment or capital under advisory, varying from start-up private companies to publicly listed equities.
NetScientific delivers shareholder returns through a proactive and hands-on management approach to their portfolio companies; identifying, investing in, and helping to build game-changing companies. The Group targets value inflection points and the release of value through partial or full exits from trade sales, public listings, or equity sales. The Company has a strong transatlantic and growing international presence, providing attractive expansion prospects.
NSCI can deploy a capital-light investment structure; utilising the power of the PLC Brand, and the NetScientific balance sheet to anchor future investments and achieve a multiplier effect by attracting 3rd party investment for the portfolio companies.
NetScientific is headquartered in London, United Kingdom, and was admitted to trading on AIM, a market operated by the London Stock Exchange, in 2013 (website: www.netscientific.net).